Novartis India share news and announcements
NSE: NOVARTINDBSE: 500672Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,684.50.
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹4,505 Cr1,055th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 23 Jul 2026
- 46.1
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 5.5
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 23 Jul 2026
- 12.2%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 23 Jul 2026
- 12.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 1,46,21823.7% delivered
Novartis India share news and announcements
606 announcements, routine notices left out, newest first. Page 4 of 13.
May 2024
Apr 2024
10 Apr · Compliances - Compliance Certificate For The Period Ended March 31, 2024
Mar 2024
27 Mar · Board meeting
Meeting on 10 May 2024: audited results and final dividend
Feb 2024
20 Feb · Meeting
Jan 2024
25 Jan · Management
Dec 2023
27 Dec · Board meeting
Meeting on 25 Jan 2024: quarterly results
Oct 2023
3 Oct · Board meeting
Meeting on 27 Oct 2023: quarterly results
Sep 2023
21 Sep · Business Responsibility and Sustainability Reporting (BRSR)
15 Sep · Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Jul 2023
28 Jul · Meeting
Jun 2023
30 Jun · Board meeting
Meeting on 26 Jul 2023: quarterly results
May 2023
Apr 2023
29 Apr · Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
14 Apr · Compliances For The Financial Year Ended March 31, 2023
Mar 2023
31 Mar · Board meeting
31 Mar · Board meeting
Meeting on 10 May 2023: special dividend, dividend, final dividend and audited results
Feb 2023
Dec 2022
27 Dec · Board meeting
Meeting on 8 Feb 2023: quarterly results
Nov 2022